337PFirst Canadian interim analysis from the phase IIIb CompLEEment-1 ribociclib + letrozole HR+ HER2- advanced breast cancer trial
Ferrario, C, Warner, E, Califaretti, N, Joy, A A, Chia, S, Wu, J, Zarate, J P, Lakshmi, M, Perri, S R, Haftchenary, S, Dent, S FVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz242.032
Date:
October, 2019
File:
PDF, 90 KB
2019